Effect of Homeobox A13 transfection on epithelial-mesenchymal transition and bone morphogenetic protein-7 expression in kidney tubular epithelial cells
PENG Li, HE Qing-Nan, LI Xiao-Yan, SHUAI Lan-Jun, CHEN Hai-Xia, LI Yong-Zhen, YI Zhu-Wen
Department of Pediatric Nephrology, Chidren's Medical Center, Second Xiangya Hospital, Central South University, Changsha 410011, China
Abstract Objective To examine the transfection of Homeobox A13(HOXA13) on epithelial-mesenchymal transition (EMT) and the expression of bone morphogenetic protein-7(BMP-7) induced by albumin-overload in human kidney tubular epithelial cells (HKCs). Methods The cultured HKCs were treated with 20 mg/mL human serum albumin (HSA) for 48 hours. Protein expression of cytokeratin (CK), vimentin and HOXA13 in the HKCs was assessed by Western blot. Protein expression of CK, vimentin, and BMP-7 was also detected in HKCs transfected with lipofectamine contained HOXA13 DNA. Results HSA induced EMT in HKCs, presented by decreased CK expression (PPPPConclusions Transfection of HOXA13 in HKCs could inhibit the degree of EMT induced by albumin-overload, possibly by increasing BMP-7 expression.
PENG Li,HE Qing-Nan,LI Xiao-Yan et al. Effect of Homeobox A13 transfection on epithelial-mesenchymal transition and bone morphogenetic protein-7 expression in kidney tubular epithelial cells[J]. CJCP, 2015, 17(12): 1342-1347.
PENG Li,HE Qing-Nan,LI Xiao-Yan et al. Effect of Homeobox A13 transfection on epithelial-mesenchymal transition and bone morphogenetic protein-7 expression in kidney tubular epithelial cells[J]. CJCP, 2015, 17(12): 1342-1347.
Eddy AA. Overview of the cellular and molecular basis of kidney fibrosis[J]. Kidney Int Suppl (2011), 2014, 4(1):2-8.
[2]
Prunotto M, Budd DC, Gabbiani G, et al. Epithelialmesenchymal crosstalk alteration in kidney fibrosis[J]. J Pathol, 2012, 228(2):131-147.
[3]
Wang Z, Zhao J, Zhang J, et al. Protective effect of BMP-7 against aristolochic acid-induced renal tubular epithelial cell injury[J]. Toxicol Lett, 2010, 198(3):348-357.
Parker L, Mangwani J, Wakeling E, et al. Hallux valgus interphalangeus and a novel mutation in HOXA13. Part of the broadening spectrum of Hand-Foot-Genital syndrome[J]. Foot Ankle Surg, 2011, 17(2):e28-e30.
[7]
Hamasaki Y, Doi K, Okamoto K, et al. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor simvastatin ameliorates renal fibrosis through HOXA13-USAG-1 pathway[J]. Lab Invest, 2012, 92(8):1161-1170.
[8]
Williams TM, Williams ME, Heaton JH, et al. Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability[J]. Nucleic Acids Res, 2005, 33(14):4475-4484.
Imagawa E, Kayserili H, Nishimura G, et al. Severe manifestations of hand-foot-genital syndrome associated with a novel HOXA13 mutation[J]. Am J Med Genet A, 2014, 164A(9):2398-2402.
[12]
Li RX, Yiu WH, Tang SC. Role of bone morphogenetic protein-7 in renal fibrosis[J]. Front Physiol, 2015, 6:114.
Morgan EA, Nguyen SB, Scott V, et al. Loss of BMP7 and Fgf8 signaling in Hoxa13-mutant mice causes hypospadia[J]. Development, 2003, 130(14):3095-3109.
[15]
Knosp WM, Scott V, Bachinger HP, et al. HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis[J]. Development, 2004, 131(18): 4581-4592.
